Sudeep Pharma Limited (SUDEEPPHRM.BO)
BSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic
₹1,021.90 (+3.95%) as of
Key statistics
- Market cap
- 115.42B
- P/E (TTM)
- 62.65
- Forward P/E
- 53.36
- EPS (TTM)
- 16.31
- Dividend yield
- 0.15%
- 52-week range
- 524.95 – 1,376.00
- Revenue (TTM)
- 6.76B
- Profit margin
- 27.03%
- Analyst target
- ₹988.00
- Volume
- 31.87k
About Sudeep Pharma Limited
Sudeep Pharma Limited manufactures and sells excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries in India, the United States, and internationally. The company provides mineral salts, such as iron, calcium, sodium, zinc, copper, magnesium, manganese, potassium, picolinates, simethicone, and others;It also offers micronutrient premixes and liposomal, encapsulated ingredients, spray-dried formats, granulated ingredients, and triturated for sports nutrition, medical and clinical nutrition, infant nutrition, beverages, fortified staples, functional foods, and dairy products. In addition, the company provides a range of mineral powders and granules for carbonated, non-carbonated, and nutraceutical beverages; tricalcium phosphate, dicalcium phophate, dipotassium phosphate, ferric pyrophosphate, and disodium phosphate. Sudeep Pharma Limited was incorporated in 1989 and is based in Vadodara, India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Vadodara, India
- Employees
- 525
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.